122 related articles for article (PubMed ID: 21761764)
1. [Synthetic protease inhibitors for the treatment of DIC].
Takahashi H
Rinsho Byori; 2011 Feb; Suppl 147():152-8. PubMed ID: 21761764
[No Abstract] [Full Text] [Related]
2. [Anti DIC therapy].
Yahata M; Sakamoto Y
Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of disseminated intravascular coagulation with proteinase inhibitor].
Okamoto K; Takeda S; Ohsato K
Nihon Rinsho; 1991 Sep; 49(9):2130-5. PubMed ID: 1960878
[No Abstract] [Full Text] [Related]
4. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
7. Application of a synthetic serine protease inhibitor in the treatment of DIC.
Kosaki G; Kambayashi J; Imaoka S
Bibl Haematol; 1983; (49):317-27. PubMed ID: 6230076
[No Abstract] [Full Text] [Related]
8. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
9. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
[No Abstract] [Full Text] [Related]
11. Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
Taenaka N; Shimada Y; Kawai M; Yoshiya I; Kosaki G
Anaesthesia; 1981 Apr; 36(4):389-93. PubMed ID: 6787945
[TBL] [Abstract][Full Text] [Related]
12. Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
Murakawa M; Okamura T; Shibuya T; Harada M; Otsuka T; Niho Y
Ann Hematol; 1992 May; 64(5):249-52. PubMed ID: 1623061
[TBL] [Abstract][Full Text] [Related]
13. [Effects of new protease inhibitor (FUT-175) on experimental DIC].
Denno R; Hasegawa I; Sasaki K; Gotoh Y; Ebata T; Totsuka M; Hayasaka H
Masui; 1984 Feb; 33(2):125-30. PubMed ID: 6716646
[No Abstract] [Full Text] [Related]
14. The effect of a serine proteinase inhibitor on DIC in septic abortion.
Takeda S; Kume M; Takechi K; Kasamatsu T; Yoshida K; Kinoshita K; Mizuno M; Sakamoto S
Asia Oceania J Obstet Gynaecol; 1987 Dec; 13(4):433-9. PubMed ID: 3122713
[No Abstract] [Full Text] [Related]
15. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
Isobe J
Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].
Yasunaga M; Mori K; Yamashita S; Okita K
Nihon Rinsho; 1991 Sep; 49(9):2120-4. PubMed ID: 1960877
[No Abstract] [Full Text] [Related]
18. Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.
Kumon K; Tanaka K; Nakajima N; Naito Y; Fujita T
Crit Care Med; 1984 Dec; 12(12):1039-43. PubMed ID: 6439471
[TBL] [Abstract][Full Text] [Related]
19. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
20. [Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
Taniguchi N; Kitani T; Kawagoe H; Horiuchi A; Masaoka T; Yasunaga K; Okamoto Y; Ohkubo A; Yonezawa T; Nagai K
Rinsho Ketsueki; 1987 Oct; 28(10):1729-37. PubMed ID: 3133506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
